Table 3.
Multivariate logistic regression model examining those who achieved short-term success†
| Characteristic* | Adjusted Odds Ratio (95% Confidence Interval) |
P value |
|---|---|---|
| Age (years) | 1.01 (0.99–1.04) | 0.34 |
| Race | ||
| White | Ref | |
| Black | 0.35 (0.11–1.07) | 0.07 |
| Hispanic/Latino | 0.58 (0.21–1.65) | 0.31 |
| Other | 0.75 (0.25–2.22) | 0.60 |
| Gender | ||
| Female | Ref | |
| Male | 1.74 (0.67–4.56) | 0.26 |
| Activation score | 1.01 (0.99–1.04) | 0.34 |
| Barriers to medication adherence | ||
| None | Ref | |
| One or more | 0.34 (0.11–1.06) | 0.06 |
| Monitor BP at home | ||
| No | Ref | |
| Yes | 1.62 (0.75–3.50) | 0.22 |
| PHQ-2 positive | ||
| No | Ref | |
| Yes | 0.42 (0.19–0.93) | 0.03 |
| SBP 9 months prior to eligibility (mmHg) | 0.94 (0.91–0.97) | <0.01 |
| Preferred decision making style | ||
| Shared | Ref | |
| PCP primarily | 0.68 (0.32–1.46) | 0.32 |
| Patient primarily | 0.84 (0.27–2.60) | 0.76 |
*
Site of care was also included in the model and non-significant
†
Short-term success was defined as being discharged from the AIM program with pharmacist documentation that all medication adherence issues had been addressed and achievement of the target blood pressure.